With the increasing incidence and prevalence of Pca and of benign prostate hyperplasia (BPH) worldwide due to the aging of the population and to the advent of routine prostate-specific antigen (PSA) screening, prostate tumors are increasingly considered as chronic diseases. The gene discussed is KLK3; the disease is benign prostatic hyperplasia.